{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:31:54Z","timestamp":1760488314494,"version":"build-2065373602"},"reference-count":46,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2025.2889","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T07:07:52Z","timestamp":1755155272000},"page":"1-6","source":"Crossref","is-referenced-by-count":0,"title":["Retroperitoneal leiomyosarcoma with metastasis to the skin (Review)"],"prefix":"10.3892","volume":"23","author":[{"given":"Qais","family":"Baheen","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Tumor Center, Beijing Arion Cancer, Beijing 102600, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tumor Center, Beijing Arion Cancer, Beijing 102600, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanlin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tumor Center, Beijing Arion Cancer, Beijing 102600, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangping","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tumor Center, Beijing Arion Cancer, Beijing 102600, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beijing Arion Cancer, Beijing 102600, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Tumor Center, Beijing Arion Cancer, Beijing 102600, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"issue":"2788584","key":"key20251014162128_b1-MCO-23-5-02889","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/2788584","article-title":"Recurrence leiomyosarcoma of the popliteal vein: A rare soft tissue sarcoma","volume":"2023","author":"Poosiripinyo","year":"2023","journal-title":"Case Rep Surg"},{"key":"key20251014162128_b2-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1245\/s10434-022-11806-8","article-title":"Prognostic factors for leiomyosarcoma with isolated metastases to the lungs: Impact of metastasectomy","volume":"29","author":"Stork","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"key20251014162128_b3-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/1097-0142(20010515)91:10<1914::aid-cncr1214>3.0.co;2-3","article-title":"Predictive value of grade for metastasis development in adult soft tissue sarcomas: A Study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group","volume":"91","author":"Coindre","year":"2001","journal-title":"Cancer"},{"issue":"258","key":"key20251014162128_b4-MCO-23-5-02889","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2025.15004","article-title":"Primary leiomyosarcoma of the ureter: A case report","volume":"29","author":"Baio","year":"2025","journal-title":"Oncol Lett"},{"issue":"778","key":"key20251014162128_b5-MCO-23-5-02889","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2017.778","article-title":"Retromammary fat, axillary and arm metastases from a retroperitoneal leiomyosarcoma: Report of a case with an indolent behaviour","volume":"11","author":"Filho","year":"2017","journal-title":"Ecancermedicalscience"},{"issue":"5970","key":"key20251014162128_b6-MCO-23-5-02889","doi-asserted-by":"publisher","DOI":"10.4081\/rt.2015.5970","article-title":"Subcutaneous axillary and scalp metastases from non-gynecological retroperitoneal leiomyosarcoma: An unusual presentation after surgical resection","volume":"7","author":"Kaur","year":"2015","journal-title":"Rare Tumors"},{"key":"key20251014162128_b7-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2165\/00128071-200809030-00008","article-title":"Superficial cutaneous leiomyosarcoma: A rare, misleading tumor","volume":"9","author":"De Giorgi","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"key20251014162128_b8-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"7873","DOI":"10.1245\/s10434-021-09654-z","article-title":"Management of primary retroperitoneal sarcoma (RPS) in the Adult: An Updated consensus Approach from the Transatlantic Australasian RPS Working Group","volume":"28","author":"Swallow","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"81","key":"key20251014162128_b9-MCO-23-5-02889","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-8-81","article-title":"Intraabdominal and retroperitoneal soft-tissue sarcomas-outcome of surgical treatment in primary and recurrent tumors","volume":"8","author":"Sogaard","year":"2010","journal-title":"World J Surg Oncol"},{"key":"key20251014162128_b10-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/SLA.0000000000000869","article-title":"Lessons learned from the Study of 10,000 patients with soft tissue sarcoma","volume":"260","author":"Brennan","year":"2014","journal-title":"Ann Surg"},{"key":"key20251014162128_b11-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"iv51","DOI":"10.1093\/annonc\/mdy096","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN clinical Practice guidelines for diagnosis, treatment and follow-up","volume":"29 (Suppl 4)","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"key":"key20251014162128_b12-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1002\/cncr.26590","article-title":"Sarcoma metastases to the skin: A clinicopathologic study of 65 patients","volume":"118","author":"Wang","year":"2012","journal-title":"Cancer"},{"issue":"1375483","key":"key20251014162128_b13-MCO-23-5-02889","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2024.1375483","article-title":"Leiomyosarcoma of the abdomen and retroperitoneum: A systematic review","volume":"11","author":"\u00d8ines","year":"2024","journal-title":"Front Surg"},{"key":"key20251014162128_b14-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/NEJMra041866","article-title":"Soft-tissue sarcomas in adults","volume":"353","author":"Clark","year":"2005","journal-title":"N Engl J Med"},{"author":"Antonescu","key":"key20251014162128_b15-MCO-23-5-02889"},{"key":"key20251014162128_b16-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2214\/ajr.144.2.355","article-title":"CT of soft-tissue neoplasms","volume":"144","author":"Weekes","year":"1985","journal-title":"AJR Am J Roentgenol"},{"issue":"642","key":"key20251014162128_b17-MCO-23-5-02889","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10090642","article-title":"Retroperitoneal sarcomas: An Update on the Diagnostic pathology update Approach","volume":"10","author":"Choi","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"key20251014162128_b18-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1440-1827.2000.01001.x","article-title":"Immunohistochemical detection of cytokeratin and epithelial membrane antigen in leiomyosarcoma: A systematic study of 100 cases","volume":"50","author":"Iwata","year":"2000","journal-title":"Pathol Int"},{"issue":"2036361318820171","key":"key20251014162128_b19-MCO-23-5-02889","doi-asserted-by":"publisher","DOI":"10.1177\/2036361318820171","article-title":"Soft tissue leiomyosarcoma-diagnostics management and prognosis: Data of the registry cancer of the center of Tunisia","volume":"11","author":"Mestiri","year":"2019","journal-title":"Rare Tumors"},{"key":"key20251014162128_b20-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1002\/1097-0142(19921215)70:12<2816::aid-cncr2820701215>3.0.co;2-4","article-title":"Prognostic significance of histologic parameters of soft tissue sarcomas","volume":"70","author":"Hashimoto","year":"1992","journal-title":"Cancer"},{"key":"key20251014162128_b21-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.humpath.2023.11.009","article-title":"Prognostic value of mitotic count in leiomyosarcoma: A comprehensive monocentric retrospective study","volume":"143","author":"Grimaudo","year":"2024","journal-title":"Hum Pathol"},{"key":"key20251014162128_b22-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ad.2017.08.005","article-title":"Clinical and histopathologic findings of cutaneous leiomyosarcoma: Correlation with prognosis in 12 patients","volume":"109","author":"Rodr\u00edguez-Lomba","year":"2018","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"key20251014162128_b23-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/0360-3016(95)02262-7","article-title":"Malignant fibrous histiocytoma: Outcome and prognostic factors following conservation surgery and radiotherapy","volume":"34","author":"Zagars","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20251014162128_b24-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/PAS.0000000000001389","article-title":"Comparative study of myxofibrosarcoma with undifferentiated pleomorphic sarcoma: Histopathologic and clinicopathologic review","volume":"44","author":"Yoshimoto","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"15494","key":"key20251014162128_b25-MCO-23-5-02889","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94834-w","article-title":"Prognostic value of CD34 expression status in patients with in myxofibrosarcomas and undifferentiated pleomorphic sarcomas","volume":"11","author":"Sugiura","year":"2021","journal-title":"Sci Rep"},{"key":"key20251014162128_b26-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11864-011-0140-x","article-title":"Histology-driven chemotherapy in soft tissue sarcomas","volume":"12","author":"Scurr","year":"2011","journal-title":"Curr Treat Options Oncol"},{"key":"key20251014162128_b27-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","article-title":"Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: A randomised controlled phase 3 trial","volume":"15","author":"Judson","year":"2014","journal-title":"Lancet Oncol"},{"key":"key20251014162128_b28-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1002\/cncr.32795","article-title":"Doxorubicin plus dacarbazine doxorubicin plus ifosfamide or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group","volume":"126","author":"D'Ambrosio","year":"2020","journal-title":"Cancer"},{"key":"key20251014162128_b29-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1200\/JCO.2010.33.6107","article-title":"Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: A Spanish Group for Research on Sarcomas study","volume":"29","author":"Garcia-del-Muro","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20251014162128_b30-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S1470-2045(17)30622-8","article-title":"Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): A randomised controlled phase 3 trial","volume":"18","author":"Seddon","year":"2017","journal-title":"Lancet Oncol"},{"issue":"S1030","key":"key20251014162128_b31-MCO-23-5-02889","article-title":"A randomised, multicenter phase-III study comparing doxorubicin (dox) alone versus dox with trabectedin (trab) followed by trab in non-progressive patients (pts) as first-line therapy, in pts with metastatic or unresectable leiomyosarcoma (LMS): Final results of the LMS-04 study (Abstract 1913O)","volume":"34","author":"Pautier","year":"2023","journal-title":"Ann Oncol"},{"key":"key20251014162128_b32-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"van der Graaf","year":"2012","journal-title":"Lancet"},{"issue":"abstr 11503","key":"key20251014162128_b33-MCO-23-5-02889","article-title":"Anlotinib for metastatic STS: Randomized trial","volume":"36 (Suppl 15)","author":"Chi","year":"2018","journal-title":"J Clin Oncol"},{"key":"key20251014162128_b34-MCO-23-5-02889","first-page":"106","article-title":"Anlotinib + chemotherapy in advanced LMS","volume":"4","author":"Zhuang","year":"2021","journal-title":"Zhonghua Zhuanyi Zhongliu Zazhi"},{"key":"key20251014162128_b35-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2020.1707","article-title":"Effect of Doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: The ANNOUNCE Randomized Clinical trial","volume":"323","author":"Tap","year":"2020","journal-title":"JAMA"},{"issue":"S11015","key":"key20251014162128_b36-MCO-23-5-02889","article-title":"Pembrolizumab in UPS and pleomorphic LPS: SARC028 final results","volume":"37 (Suppl 15)","author":"Burgess","year":"2019","journal-title":"J Clin Oncol"},{"key":"key20251014162128_b37-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejca.2021.04.034","article-title":"Immune checkpoint inhibitors in treatment of soft-tissue sarcoma: A systematic review and meta-analysis","volume":"152","author":"Saerens","year":"2021","journal-title":"Eur J Cancer"},{"key":"key20251014162128_b38-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S1470-2045(18)30006-8","article-title":"Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): Two open-label, non-comparative, randomised, phase 2 trial","volume":"19","author":"D'Angelo","year":"2018","journal-title":"Lancet Oncol"},{"issue":"11501","key":"key20251014162128_b39-MCO-23-5-02889","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-25-0618","article-title":"A single-arm, open-label phase 2 trial of doxorubicin plus zalifrelimab, a CTLA-4 inhibitor, with balstilimab, a PD-1 inhibitor, in patients with advanced\/metastatic soft tissue sarcomas (Abstract 11501)","volume":"41","author":"Wilky","year":"2023","journal-title":"J Clin Oncol"},{"issue":"11500","key":"key20251014162128_b40-MCO-23-5-02889","article-title":"Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc) (Abstract 11500)","volume":"41","author":"Reichardt","year":"2023","journal-title":"J Clin Oncol"},{"issue":"11502","key":"key20251014162128_b41-MCO-23-5-02889","article-title":"ImmunoSarc2: A Spanish Sarcoma Group (GEIS) phase Ib trial of doxorubicin and dacarbazine plus nivolumab in first-line treatment of advanced leiomyosarcoma (Abstract 11502)","volume":"41","author":"Martin-Broto","year":"2023","journal-title":"J Clin Oncol"},{"key":"key20251014162128_b42-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1600-0560.1996.tb01435.x","article-title":"Intradermal and subcutaneous leiomyosarcoma: A clinicopathological and immunohistochemical study of 41 cases","volume":"23","author":"Jensen","year":"1996","journal-title":"J Cutan Pathol"},{"key":"key20251014162128_b43-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up\u2606","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"},{"key":"key20251014162128_b44-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1200\/JCO.1997.15.1.350","article-title":"Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma","volume":"15","author":"Guillou","year":"1997","journal-title":"J Clin Oncol"},{"key":"key20251014162128_b45-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s12094-019-02196-7","article-title":"Important Prognostic factors in leiomyosarcoma survival: A National Cancer Database (NCDB) analysis","volume":"22","author":"Gootee","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"key20251014162128_b46-MCO-23-5-02889","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1245\/s10434-013-2876-y","article-title":"Predictors of Survival and recurrence in primary leiomyosarcoma","volume":"20","author":"Gladdy","year":"2013","journal-title":"Ann Surg Oncol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T13:21:36Z","timestamp":1760448096000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2025.2889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,8,14]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2025.2889","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"type":"print","value":"2049-9450"},{"type":"electronic","value":"2049-9469"}],"subject":[],"published":{"date-parts":[[2025,8,14]]}}}